These results connected the classical cAMP pathway in formoterol‐induced β2AR activation with SIRT1 upregulation and VSMC senescence alleviation, inspiring future drug discovery along the β2AR‐cAMP pathway for the medical treatment of AAA. The gene discussed is SIRT1; the disease is triple-A syndrome.